Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues:
Premiums	$ 49,394	$ 47,164	$ 100,034	$ 94,677
Products	8,247	8,353	16,678	16,425
Services	4,156	4,496	9,141	8,814
Investment and other income	341	582	706	987
Total revenues	62,138	60,595	126,559	120,903
Operating costs:
Medical costs	34,678	39,184	75,678	78,123
Operating costs	10,001	8,415	20,016	16,932
Cost of products sold	7,501	7,598	15,188	14,979
Depreciation and amortization	717	654	1,440	1,293
Total operating costs	52,897	55,851	112,322	111,327
Earnings from operations	9,241	4,744	14,237	9,576
Interest expense	(430)	(418)	(867)	(818)
Earnings before income taxes	8,811	4,326	13,370	8,758
Provision for income taxes	(2,115)	(941)	(3,209)	(1,816)
Net earnings	6,696	3,385	10,161	6,942
Earnings attributable to noncontrolling interests	(59)	(92)	(142)	(182)
Net earnings attributable to UnitedHealth Group common shareholders	$ 6,637	$ 3,293	$ 10,019	$ 6,760
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic	$ 6.99	$ 3.47	$ 10.56	$ 7.09
Diluted	$ 6.91	$ 3.42	$ 10.43	$ 6.97
Basic weighted-average number of common shares outstanding	949	950	949	954
Dilutive effect of common share equivalents	11	14	12	16
Diluted weighted-average number of common shares outstanding	960	964	961	970
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	11	11	11	9